COMMON GASTRIC MANIFESTATIONS AFTER COVID-19 SINOPHARM VACCINATION

Abstract

The COVID-19 pandemic has underscored the significance of vaccination in protecting individuals from the virus. With multiple vaccines available, this study focuses on the Sinopharm vaccine, evaluating its gastric effects on recipients in both the short and long term. Our research, based on a comprehensive analysis of participant data, reveals that the Sinopharm COVID-19 vaccine is associated with gastric discomfort, acidity, and dyspepsia-like side effects, primarily in the long term, approximately one year post-vaccination. Notably, these side effects were observed not only in the general population but also in healthcare workers who received the vaccine. The findings of this study emphasize the importance of ongoing follow-up and regular evaluations to assess the long-term implications of the Sinopharm vaccine on stomach health and overall well-being. The development of an algorithm to monitor and address stomach health responses following vaccination is crucial for effective management and prevention strategies. This research contributes to the growing body of knowledge on vaccine-related side effects, highlighting the need for continued surveillance and evaluation of vaccine safety to inform evidence-based public health decisions.